The LONG-TERM GOAL of our proposal is to understand both the physiologic and etiological bases of the neurobehavioural changes of patients with dominantly-inherited olivopontocerebellar atrophy (OPCA), a cerebellar ataxia disorder. This will be accomplished through neurobehavioural and brain neurochemical and neuropathological examination of 30 patients from five U.S. OPCA families. The four specific aims of our interdisciplinary study are the following: 1) to understand in OPCA the role of the brain cholinergic system and the,cerebellum in the cognitive deficits typical of patients with frontal lobe damage; 2) to provide a biochemical explanation for the excitatory amino acid and phospholipid metabolite changes in OPCA brain; 3) to investigate the possibility of a """"""""dying-back"""""""" phenomenon involving the OPCA nigrostriatal dopamine neurone; and 4) to improve the quality of life of our OPCA patients through dysphagia intervention. The SPECIAL FEATURES of our proposal include the unique ability of the applicants to follow prospectively and carefully patients from five U.S. OPCA families with annual neurobehavioural assessment until autopsy, and the demonstrated expertise of each of the applicants in the relevant neurobehavioural assessment, dysphagia intervention, and human brain neurochemical and neuropathological techniques. We suggest that the information to be obtained is important in its own right for characterizing aspects of a disorder which have been relatively neglected by the scientific community and, more generally, is likely to lead to new brain-behavioural correlations relevant to our understanding of both normal and abnormal brain functioning.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS026034-05
Application #
3411631
Study Section
Neurology A Study Section (NEUA)
Project Start
1988-06-01
Project End
1994-05-31
Budget Start
1992-06-01
Budget End
1993-05-31
Support Year
5
Fiscal Year
1992
Total Cost
Indirect Cost
Name
University of Toronto
Department
Type
DUNS #
259999779
City
Toronto
State
ON
Country
Canada
Zip Code
M5 1-S8
Haycock, John W; Becker, Laurence; Ang, Lee et al. (2003) Marked disparity between age-related changes in dopamine and other presynaptic dopaminergic markers in human striatum. J Neurochem 87:574-85
Morrison, L D; Cao, X C; Kish, S J (1998) Ornithine decarboxylase in human brain: influence of aging, regional distribution, and Alzheimer's disease. J Neurochem 71:288-94
Montermini, L; Kish, S J; Jiralerspong, S et al. (1997) Somatic mosaicism for Friedreich's ataxia GAA triplet repeat expansions in the central nervous system. Neurology 49:606-10
Mastrogiacoma, F; Lindsay, J G; Bettendorff, L et al. (1996) Brain protein and alpha-ketoglutarate dehydrogenase complex activity in Alzheimer's disease. Ann Neurol 39:592-8
Bettendorff, L; Mastrogiacomo, F; LaMarche, J et al. (1996) Brain levels of thiamine and its phosphate esters in Friedreich's ataxia and spinocerebellar ataxia type 1. Mov Disord 11:437-9
Morrison, L D; Smith, D D; Kish, S J (1996) Brain S-adenosylmethionine levels are severely decreased in Alzheimer's disease. J Neurochem 67:1328-31
Mastrogiacomo, F; LaMarche, J; Dozic, S et al. (1996) Immunoreactive levels of alpha-ketoglutarate dehydrogenase subunits in Friedreich's ataxia and spinocerebellar ataxia type 1. Neurodegeneration 5:27-33
Mastrogiacoma, F; Bettendorff, L; Grisar, T et al. (1996) Brain thiamine, its phosphate esters, and its metabolizing enzymes in Alzheimer's disease. Ann Neurol 39:585-91
Ross, B M; Kim, D K; Bonventre, J V et al. (1995) Characterization of a novel phospholipase A2 activity in human brain. J Neurochem 64:2213-21
Kish, S J; Zhong, X H; Hornykiewicz, O et al. (1995) Striatal 3,4-dihydroxyphenylalanine decarboxylase in aging: disparity between postmortem and positron emission tomography studies? Ann Neurol 38:260-4

Showing the most recent 10 out of 31 publications